Sulodexide Recruiting Phase 3 Trials for Venous Thromboembolism / Anticoagulant Therapy / Elderly Prevention

IndicationsStatusPurposePhase
RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04257487Sulodexide, VESSELĀ®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)